Rallybio Corporation (RLYB) Options Chain

The options chain displays all available contracts with end-of-day quotes, Greeks, volume, and open interest for each strike and expiration, and streams live quotes for traders who connect a broker. It is the primary tool for options trade selection.

Rallybio Corporation (RLYB) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $89.2M, listed on NASDAQ, employing roughly 7 people, carrying a beta of -0.86 to the broader market. Rallybio Corporation is a clinical-stage biotechnology firm dedicated to discovering and bringing to market transformative therapies for individuals facing severe and uncommon illnesses. Led by Stephen Uden, public since 2021-07-29.

The options chain displays all available contracts with quotes, Greeks, and open interest. No recent options activity for RLYB as of 2026-08-31; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how the options chain is reported and how to read the data →